Bgm (BGM) Total Liabilities (2019 - 2025)
Bgm (BGM) posted quarterly Total Liabilities of $41.9 million for Q3 2025, up 370.43% year-over-year from $8.9 million in Q3 2024, and up 75.37% quarter-over-quarter from $23.9 million in Q1 2025.
Bgm (BGM) Total Liabilities (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Total Liabilities for 7 consecutive years, with $41.9 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Total Liabilities rose 370.43% year-over-year to $41.9 million; the TTM figure through Sep 2025 stood at $41.9 million (up 370.43% YoY), while the FY2025 annual figure was $41.9 million, up 370.43% from the prior year.
- Total Liabilities grew to $41.9 million in Q3 2025 per BGM's latest filing, from $23.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $41.9 million in Q3 2025 and bottomed at $9.5 in Q1 2023.
- Historically, Total Liabilities has averaged $11.5 million across 5 years, with a median of $7.9 million in 2023.
- Annual changes were most pronounced in 2022 — Total Liabilities plunged 67.68% — and 2024, when it jumped 51917632.95%.
- Bgm's Total Liabilities stood at $18.7 million in 2021, then slumped by 48.82% to $9.6 million in 2022, then declined by 27.78% to $6.9 million in 2023, then climbed by 29.01% to $8.9 million in 2024, then surged by 370.43% to $41.9 million in 2025.
- Business Quant data shows BGM's Total Liabilities at $41.9 million in Q3 2025, $23.9 million in Q1 2025, and $8.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 41.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 41.92 Mn |
| Mar 31, 2025 | 23.90 Mn |
| Sep 30, 2024 | 8.91 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Sep 30, 2023 | 6.91 Mn |
| Mar 31, 2023 | 9.50 |
| Sep 30, 2022 | 9.56 Mn |
| Mar 31, 2022 | 22.64 |
| Sep 30, 2021 | 18.68 Mn |
| Mar 31, 2021 | 70.04 |
| Sep 30, 2020 | 19.30 Mn |
| Sep 30, 2019 | 12.63 Mn |